Drug use and access to drug dependency services for vulnerable migrants who use drugs in the European Union : Consensus statements and recommendations from civil society experts in Europe
Copyright © 2023. Published by Elsevier B.V..
BACKGROUND: The number of migrants in the European Union (EU) has been growing, including migrants at risk of using drugs. Little information is available on the actual drug use among first-generation migrants who use drugs in the EU, nor on their access to drug dependency services. This study aims to reach consensus among experts in the EU on the current situation regarding vulnerable migrants who use drugs in the EU and to develop a set of actionable recommendations.
METHODS: Between April and September 2022, a panel of 57 experts on migration and/or drug use, working in 24 countries, participated in a three-stage Delphi study to develop statements and recommendations about drug use and access to healthcare services for migrants who use drugs in the EU.
RESULTS: High levels of agreement were reached on the 20 statements (mean=98.0%) and 15 recommendations (mean=99.7%). The recommendations focus on four main topics; 1) increasing data availability and quality, to inform guidelines; 2) increasing the availability of drug dependency services for migrants, including screening for mental health issues and involving migrants who use drugs in the development of services; 3) eliminating country and service level barriers for accessing these services, as well as providing migrants who use drugs with suitable information, and combating stigma and discrimination; 4) the need for increased collaboration among and within EU countries regarding healthcare for migrants who use drugs, at the policy level as well as the service level, including civil society organisations, peer navigation and multilingual cultural mediators.
CONCLUSION: Policy action and increased collaboration are required by the EU as a whole and by individual EU member states, in addition to collaboration among healthcare providers and social welfare services, to increase access to healthcare services for migrants who use drugs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:118 |
|---|---|
| Enthalten in: |
The International journal on drug policy - 118(2023) vom: 01. Aug., Seite 104087 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
van Selm, Lena [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Addiction |
|---|
| Anmerkungen: |
Date Completed 24.07.2023 Date Revised 24.07.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.drugpo.2023.104087 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358094941 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358094941 | ||
| 003 | DE-627 | ||
| 005 | 20231226074019.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.drugpo.2023.104087 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1193.xml |
| 035 | |a (DE-627)NLM358094941 | ||
| 035 | |a (NLM)37307786 | ||
| 035 | |a (PII)S0955-3959(23)00135-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a van Selm, Lena |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drug use and access to drug dependency services for vulnerable migrants who use drugs in the European Union |b Consensus statements and recommendations from civil society experts in Europe |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.07.2023 | ||
| 500 | |a Date Revised 24.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023. Published by Elsevier B.V. | ||
| 520 | |a BACKGROUND: The number of migrants in the European Union (EU) has been growing, including migrants at risk of using drugs. Little information is available on the actual drug use among first-generation migrants who use drugs in the EU, nor on their access to drug dependency services. This study aims to reach consensus among experts in the EU on the current situation regarding vulnerable migrants who use drugs in the EU and to develop a set of actionable recommendations | ||
| 520 | |a METHODS: Between April and September 2022, a panel of 57 experts on migration and/or drug use, working in 24 countries, participated in a three-stage Delphi study to develop statements and recommendations about drug use and access to healthcare services for migrants who use drugs in the EU | ||
| 520 | |a RESULTS: High levels of agreement were reached on the 20 statements (mean=98.0%) and 15 recommendations (mean=99.7%). The recommendations focus on four main topics; 1) increasing data availability and quality, to inform guidelines; 2) increasing the availability of drug dependency services for migrants, including screening for mental health issues and involving migrants who use drugs in the development of services; 3) eliminating country and service level barriers for accessing these services, as well as providing migrants who use drugs with suitable information, and combating stigma and discrimination; 4) the need for increased collaboration among and within EU countries regarding healthcare for migrants who use drugs, at the policy level as well as the service level, including civil society organisations, peer navigation and multilingual cultural mediators | ||
| 520 | |a CONCLUSION: Policy action and increased collaboration are required by the EU as a whole and by individual EU member states, in addition to collaboration among healthcare providers and social welfare services, to increase access to healthcare services for migrants who use drugs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Addiction | |
| 650 | 4 | |a Drug use | |
| 650 | 4 | |a European Union | |
| 650 | 4 | |a Harm reduction | |
| 650 | 4 | |a Healthcare access | |
| 650 | 4 | |a Migrant health | |
| 700 | 1 | |a White, Trenton M |e verfasserin |4 aut | |
| 700 | 1 | |a Picchio, Camila A |e verfasserin |4 aut | |
| 700 | 1 | |a Requena-Méndez, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Busz, Machteld |e verfasserin |4 aut | |
| 700 | 1 | |a Bakker, Ingrid |e verfasserin |4 aut | |
| 700 | 1 | |a Romero, Diana |e verfasserin |4 aut | |
| 700 | 1 | |a Perez Gayo, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Pouille, Aline |e verfasserin |4 aut | |
| 700 | 1 | |a Vanderplasschen, Wouter |e verfasserin |4 aut | |
| 700 | 1 | |a Lazarus, Jeffrey V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The International journal on drug policy |d 1996 |g 118(2023) vom: 01. Aug., Seite 104087 |w (DE-627)NLM089798821 |x 1873-4758 |7 nnns |
| 773 | 1 | 8 | |g volume:118 |g year:2023 |g day:01 |g month:08 |g pages:104087 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.drugpo.2023.104087 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 118 |j 2023 |b 01 |c 08 |h 104087 | ||